MAPK3 and breast carcinoma: Repression of DUSP3 expression increased the phospho-ERK1/2 levels in HeLa cells[24], non–small cell lung cancer cells(H1792 and H460)[25] and breast cancer cells(MCF-7 and SKBR3)[26].